Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Oct 17, 2016 5:16pm

106 Views

Post# 25353097

RE:Italian sensation Dr.Claudio Ronco...

My guess on that Ronco quote is that he thought the EUPHRATES was an abdominal sepsis trial, just like the Italian trial. But nowhere (to my knowledge) do official documents state that the EUPHRATES trial was an abdominal sepsis trial. Maybe that accounts for different results.

Bullboard Posts

Crypto and blockchain stock ends year with a profit